Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples. Issue 2 (27th September 2019)

• Record Type: Journal Article
• Authors: Zito Marino, Federica; Rossi, Giulio; Cozzolino, Immacolata; Montella, Marco; Micheli, Mariacarolina; Bogina, Giuseppe; Munari, Enrico; Brunelli, Matteo; Franco, Renato
• Is Part Of: Journal of clinical pathology. Volume 73:Issue 2(2020)
• Page Start: 96
• Page End: 101
• Publication Date: 2019-09-27
• Subjects: FISH -- lung cancer -- molecular biology -- molecular pathology; Pathology -- Periodicals; Pathology, Molecular -- Periodicals; 616.0705
• DOI: 10.1136/jclinpath-2019-206152
• Languages: English
• ISSNs: 0021-9746

Abstract

Abstract : Aims: Several predictive biomarkers of response to specific inhibitors have become mandatory for the therapeutic choice in non-small-cell lung cancer (NSCLC). In most lung cancer patients, the biological materials available to morphological and molecular diagnosis are exclusively cytological samples and minimum tumour wastage is necessary. Multiplex fluorescence in situ hybridisation (mFISH) to detect simultaneously ALK- rearrangement and ROS1- rearrangement on a single slide could be useful in clinical practice to save cytological samples for further molecular analysis. In this study, we aim to validate diagnostic performance of multiplex ALK/ROS1 fluorescence in situ hybridisation (FISH) approach in lung adenocarcinoma cytological series compared with classic single break apart probes. Methods: We collected a series of 61 lung adenocarcinoma cytological specimens enriched in tumours harbouring ALK- rearrangement and ROS1- rearrangement. ALK and ROS1 status were previously assessed by classic FISH test using single break apart probes and immunohistochemistry. Study population was composed of 6 ALK -positive, 2 ROS1 -positive and 53 ALK/ROS1 -wild type. All specimens were analysed by multiplex FISH assay using FlexISH ALK/ROS1 DistinguISH Probe Zytovision. Results: The dual ALK/ROS1 FISH probe test results were fully concordant with the results of previous single ALK and ROS1 FISH tests on two different slides. 6 ALK -positive and 2 ROS1 -positive were confirmed through multiplex FISH test, without false-positive and false-negative results. Multiplex ALK/ROS1 FISH test results agreed with immunohistochemistry assay staining results. Conclusion: Multiplex ALK/ROS1 FISH probe test is a useful tool to detect simultaneously ALK- rearrangement and ROS1- rearrangement on a single slide in cytological specimens with a small amount of biomaterial.